Format

Send to

Choose Destination
See comment in PubMed Commons below
Mol Ther. 2009 Feb;17(2):219-30. doi: 10.1038/mt.2008.254. Epub 2008 Dec 9.

Cancer stem cell-directed therapies: recent data from the laboratory and clinic.

Author information

1
Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Palo Alto, California, USA. cypark@stanford.edu

Abstract

Cancer stem cells (CSCs) are defined by their ability to (i) fully recapitulate the tumor of origin when transplanted into immunodeficient mouse hosts, and (ii) self-renew, demonstrated by their ability to be serially transplanted. These properties suggest that CSCs are required for tumor maintenance and metastasis; thus, it has been predicted that CSC elimination is required for cure. This prediction has profoundly altered paradigms for cancer research, compelling investigators to prospectively isolate CSCs to characterize the molecular pathways regulating their behavior. Many potential strategies for CSC-directed therapy have been proposed, but few studies have rigorously demonstrated their efficacy using in vivo models. Herein, we highlight recent studies that demonstrate the utility of CSC-directed therapies and discuss the implications of the CSC hypothesis to experimental design and therapeutic strategies.

PMID:
19066601
PMCID:
PMC2835048
DOI:
10.1038/mt.2008.254
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center